Discovery of Substituted 2-oxoquinolinylthiazolidin-4-one Analogues as Potential EGFRK Inhibitors in Lung Cancer Treatment.
Soniya NaikVasu SoumyaShivlingrao N MamledesaiM ManickavasagamPrafulla ChoudhariSanket Rathod
Published in: Drug research (2024)
Among all the synthesized analogues, the binding affinity of the compound (Vh) was found to be higher than other synthesized derivatives and a molecular dynamics simulation study explored the stability of the docked complex system.